About this trial
To evaluate the diagnostic performance of arterial spin labelling (ASL) magnetic resonance perfusion in preoperative grading of pediatric brain tumors.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Pediatric patients aged 18 years or younger.
Patients with radiological diagnosis of intracranial brain tumors.
Disqualifiers
Patients who have received prior surgery, chemotherapy or radiotherapy for brain tumors.
Patients with contraindications to magnetic resonance imaging (MRI) examination.
Trial population
pediatric patients with radiological diagnosis of brain tumors
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Evaluate the diagnostic value of arterial spin labelling (ASL) magnetic resonance perfusion in pre-operative grading of pediatric brain tumors
arterial spin labelling (ASL) derived cerebral blood flow values and their correlation with histopathological tumor grade (low grade versus high grade pediatric brain tumor)
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: